Research advances on optical characteristics in central serous chorioretinopathy

doi:10.16352/j.issn.1001-6325.2024.01.0131

Abstract

Abstract: Central serous chorioretinopathy (CSC) is a chorioretinal disease that causes idiopathic serous retinal detachment (SRD), which is associated with one or more areas of pigment epithelial detachment (PED) or defect in the retinal pigment epithelium, also with characteristic ocular structural changes. CSC was classified as pachychoroid spectrum diseases (PSD); recent studies have found it mainly in Haller layer. Recent studies focused on the thick sclera in CSC patients, illustrated the close relation between which and choroidal circulation and put forward the probable pathogenesis similar to uveal effusion syndrome (UES). In addition, short axial length, hyperopia and shallow anterior chamber are also the characteristics in CSC patients, indicating that CSC is the disease not limiting to posterior oculus, but involving the whole oculus. This review summarizes the latest research advances on optical characteristics in CSC, providing the new ideas for further research on pathogenesis of CSC.

Key words: central serous chorioretinopathy, scleral thickness, axial length, anterior chamber depth, choroidal thickness

CLC Number:

R774.5

XIAO Xingyu, DAI Rongping. Research advances on optical characteristics in central serous chorioretinopathy[J]. Basic & Clinical Medicine, 2024, 44(1): 131-135.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2024.01.0131

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2024/V44/I1/131

References 25

[1]	Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities[J]. Prog Retin Eye Res, 2020, 79: 100865. doi:10.1016/j.preteyeres.2020.100865.
[2]	Imanaga N, Terao N, Nakamine S, et al. Scleral thickness in central serous chorioretinopathy[J]. Ophthalmol Retina, 2021, 5: 285-291.
[3]	Lee YJ, Lee YJ, Lee JY, et al. A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography[J]. Sci Rep, 2021, 11: 5872. doi:10.1038/s41598-021-85229-y.
[4]	Spaide RF, Fisher YL, Ngo WK, et al. Regional scleral thickness as a risk factor for central serous chorioretino-pathy[J]. Retina, 2022, 42: 1231-1237.
[5]	Mohapatra T, Trehan HS, Kurumkattil R, et al. Anterior scleral thickness in patients of central serous chorioretinopathy: a case-control study[J]. Oman J Ophthalmol, 2023, 16: 12-17.
[6]	Aichi T, Terao N, Imanaga N, et al. Scleral thickness in the fellow eyes of patients with unilateral central serous chorioretinopathy[J]. Retina, 2023, 43: 1573-1578.
[7]	Sawaguchi S, Terao N, Imanaga N, et al. Scleral thickness in steroid-induced central serous chorioretino-pathy[J]. Ophthalmol Sci, 2022, 2: 100124.
[8]	Terao N, Imanaga N, Wakugawa S, et al. Ciliochoroidal effusion in central serous chorioretinopathy[J]. Retina, 2022, 42: 730-737.
[9]	Imanaga N, Terao N, Sawaguchi S, et al. Clinical factors related to loculation of fluid in central serous chorioretinopathy[J]. Am J Ophthalmol, 2022, 235: 197-203.
[10]	Ishikura M, Muraoka Y, Nishigori N, et al. Widefield choroidal thickness of eyes with central serous chorioretinopathy examined by swept-source OCT[J]. Ophthalmol Retina, 2022, 6: 949-956.
[11]	Imanaga N, Terao N, Sonoda S, et al. Relationship between scleral thickness and choroidal structure in central serous chorioretinopathy[J]. Invest Ophthalmol Vis Sci, 2023, 64: 16. doi:10.1167/iovs.64.1.16.
[12]	Spaide RF, Gemmy CC, Matsumoto H, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders[J]. Prog Retin Eye Res, 2022, 86: 100973. doi:10.1016/j.preteyeres.2021.100973.
[13]	Terao N, Koizumi H, Kojima K, et al. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy[J]. Br J Ophthalmol, 2020, 104: 1260-1265.
[14]	Maltsev DS, Kulikov AN, Burnasheva MA, et al. Axial length as a basic anatomical predictor for morphological and clinical characteristics in acute central serous chorioretinopathy[J]. Eye (Lond), 2020, 34: 2063-2067.
[15]	Terao N, Imanaga N, Wakugawa S, et al. Short axial length is related to asymmetric vortex veins in central serous chorioretinopathy[J]. Ophthalmol Sci, 2021, 1: 100071. doi:10.1016/j.xops.2021.100071.
[16]	Ersoz MG, Arf S, Hocaoglu M, et al. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients[J]. Br J Ophthalmol, 2019, 103: 725-729.
[17]	Ravenstijn M, van Dijk E, Haarman A, et al. Myopic presentation of central serous chorioretinopathy[J]. Retina, 2021, 41: 2472-2478.
[18]	Lim LS, Lamoureux E, Saw SM, et al. Are myopic eyes less likely to have diabetic retinopathy?[J]. Ophthalmology, 2010, 117: 524-530.
[19]	Oh JH, Oh J, Togloom A, et al. Biometric characteristics of eyes with central serous chorioretinopathy[J]. Invest Ophthalmol Vis Sci, 2014, 55: 1502-1508.
[20]	Jirarattanasopa P, Ooto S, Tsujikawa A, et al. Assess-ment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy[J]. Ophthalmology, 2012, 119: 1666-1678.
[21]	Zeng Q, Yao Y, Tu S, et al. Quantitative analysis of choroidal vasculature in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography[J]. Sci Rep, 2022, 12: 18427. doi:10.1038/s41598-022-23389-1.
[22]	Nishihara S, Maruko I, Izumi T, et al. Peripheral choroidal thickness determined by wide-field optical coherence tomography in eyes with central serous chorioretinopathy[J]. Retina, 2022, 42: 1450-1454.
[23]	Izumi T, Maruko I, Kawano T, et al. Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomogra-phy[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260: 295-301.
[24]	Chung YR, Kim JW, Choi SY, et al. Subfoveal choroidal thickness and vascular diameter in active and resolved central serous chorioretinopathy[J]. Retina, 2018, 38: 102-107.
[25]	Luo Z, Xu Y, Xu K, et al. Choroidal vortex vein drainage system in central serous chorioretinopathy using ultra-widefield optical coherence tomography angiography[J]. Transl Vis Sci Technol, 2023, 12: 17. doi:10.1167/tvst.12.9.17.